瘤反应性T细胞克隆型动态,是黑色素瘤TIL治疗临床反应的基础
Johanna Chiffelle1, David Barras1, Rémy Pétremand1
1Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.
Immunity
|September 14, 2024
概括
使用瘤透性淋巴细胞 (TILs) 的采用细胞疗法 (ACT) 显示出不同的结果. 响应者最初有更多的瘤反应性TILs,这些瘤在治疗后更好地扩大和透到瘤中,与不响应者不同.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 使用体外扩大瘤透淋巴细胞 (TILs) 的采用细胞疗法 (ACT) 在黑色素瘤患者中显示出不一致的临床反应.
- 了解推动治疗成功的因素对于优化TIL-ACT至关重要.
研究的目的:
- 调查TILs从基线瘤到ACT后样本的克隆动态.
- 确定与黑色素瘤中对TIL-ACT临床反应相关的TIL克隆类型的特征.
主要方法:
- 用单细胞RNA和T细胞受体 (TCR) 测序来追踪TIL克隆类型.
- 从黑色素瘤患者的基线瘤,ACT产品以及ACT后血液和瘤样本的分析.
主要成果:
- 临床响应者在基线瘤中富含瘤反应性TILs,这些TILs有效扩大并导致ACT后瘤特异性CD8+细胞透.
- 非响应者的瘤缺乏瘤反应性TILs,他们的细胞产物主要是由血液中存在的血液中存在的克隆类型,而不是瘤.
- 瘤特异性TIL在扩张时失去了耗尽签名,响应者在移植后表现出中间耗尽的效应器状态,这表明功能复原.
结论:
- 瘤反应性TIL克隆型动态对于TIL-ACT的临床反应至关重要.
- 识别和扩展瘤特异性TIL可以提高TIL-ACT的疗效.
- 研究结果为优化黑色素瘤TIL-ACT策略提供了洞察力.
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688
Cytotoxic T Cells-mediated Immune Response
859
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


